It could be speculated that shrinkage of the PRS volume despite lack of neuropathological lesions and neuronal loss, could be due to less projections along the perforant pathway caused by entorhinal tau and hippocampal amyloid disruption. The gene discussed is MAPT; the disease is amyloidosis.